Cargando…

Whether, when and how chronic inflammation increases the risk of developing late-onset Alzheimer's disease

Neuropathological studies have revealed the presence of a broad variety of inflammation-related proteins (complement factors, acute-phase proteins, pro-inflammatory cytokines) in Alzheimer's disease (AD) brains. These constituents of innate immunity are involved in several crucial pathogenic ev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eikelenboom, Piet, Hoozemans, Jeroen JM, Veerhuis, Rob, van Exel, Eric, Rozemuller, Annemieke JM, van Gool, Willem A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506930/ https://www.ncbi.nlm.nih.gov/pubmed/22647384 http://dx.doi.org/10.1186/alzrt118

Ejemplares similares

Neuroinflammation in Alzheimer's disease wanes with age
por: Hoozemans, Jeroen JM, et al.
Publicado: (2011)

Maximal COX-2 and ppRb expression in neurons occurs during early Braak stages prior to the maximal activation of astrocytes and microglia in Alzheimer's disease
por: Hoozemans, Jeroen JM, et al.
Publicado: (2005)

Microglia activation in sepsis: a case-control study
por: Lemstra, Afina W, et al.
Publicado: (2007)

Altered distribution of the EphA4 kinase in hippocampal brain tissue of patients with Alzheimer’s disease correlates with pathology
por: Rosenberger, Andrea FN, et al.
Publicado: (2014)

MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: a diagnostic accuracy study
por: Richard, Edo, et al.
Publicado: (2013)

NG2 cells, a new trail for Alzheimer’s disease mechanisms?
por: Nielsen, Henrietta M, et al.
Publicado: (2013)

Protein Kinase Activity Decreases with Higher Braak Stages of Alzheimer’s Disease Pathology
por: Rosenberger, Andrea F.N., et al.
Publicado: (2015)

Different curcumin forms selectively bind fibrillar amyloid beta in post mortem Alzheimer’s disease brains: Implications for in-vivo diagnostics
por: den Haan, Jurre, et al.
Publicado: (2018)

Neuroinflammation is increased in the parietal cortex of atypical Alzheimer’s disease
por: Boon, Baayla D. C., et al.
Publicado: (2018)

The coarse-grained plaque: a divergent Aβ plaque-type in early-onset Alzheimer’s disease
por: Boon, Baayla D. C., et al.
Publicado: (2020)

Increased occurrence of protein kinase CK2 in astrocytes in Alzheimer’s disease pathology
por: Rosenberger, Andrea F. N., et al.
Publicado: (2016)

Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer’s disease
por: Hondius, David C., et al.
Publicado: (2018)

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas
por: den Haan, Jurre, et al.
Publicado: (2018)

The proteome of granulovacuolar degeneration and neurofibrillary tangles in Alzheimer’s disease
por: Hondius, David C., et al.
Publicado: (2021)

Is GLP‐1 a hormone: Whether and When?
por: D'Alessio, David
Publicado: (2016)

Subclinical Hypothyroidism – Whether and When To Start Treatment?
por: Cojić, Milena, et al.
Publicado: (2017)

Activation of the unfolded protein response and granulovacuolar degeneration are not common features of human prion pathology
por: Wiersma, Vera I., et al.
Publicado: (2016)

Whether and When Superhydrophobic/Superoleophobic Surfaces Are Fingerprint Repellent
por: Wu, Chengjiao, et al.
Publicado: (2022)

Label-free vibrational imaging of different Aβ plaque types in Alzheimer’s disease reveals sequential events in plaque development
por: Röhr, Dominik, et al.
Publicado: (2020)

Hypochondriacal delusion in an elderly woman recovers quickly with electroconvulsive therapy
por: Dols, Annemieke, et al.
Publicado: (2012)

Amyloid-β, p-tau and reactive microglia are pathological correlates of MRI cortical atrophy in Alzheimer’s disease
por: Frigerio, Irene, et al.
Publicado: (2021)

Dexamethasone in Patients Hospitalized with COVID-19: Whether, When and to Whom
por: Calzetta, Luigino, et al.
Publicado: (2021)

Anti-Cytomegalovirus Therapy: Whether and When to Initiate, Those Are the Questions
por: Aoyama, Yumi, et al.
Publicado: (2022)

Not When But Whether: Modality and Future Time Reference in English and Dutch
por: Robertson, Cole, et al.
Publicado: (2023)

Physiological and pathophysiological functions of cell cycle proteins in post-mitotic neurons: implications for Alzheimer’s disease
por: van Leeuwen, Lucie A. G., et al.
Publicado: (2015)

The Neuropathology of Gluten-Related Neurological Disorders: A Systematic Review
por: Rouvroye, Maxine D, et al.
Publicado: (2020)

Late onset Alzheimer’s disease in older people
por: Isik, Ahmet Turan
Publicado: (2010)

Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP
por: Jansen, Casper, et al.
Publicado: (2009)

Disturbed Ca(2+) Homeostasis Increases Glutaminyl Cyclase Expression; Connecting Two Early Pathogenic Events in Alzheimer’s Disease In Vitro
por: De Kimpe, Line, et al.
Publicado: (2012)

Costs of stroke and stroke services: Determinants of patient costs and a comparison of costs of regular care and care organised in stroke services
por: van Exel, Job, et al.
Publicado: (2003)

Testing Whether and When Abstract Symmetric Patterns Produce Affective Responses
por: Bertamini, Marco, et al.
Publicado: (2013)

Case report: Chronic pain in a pediatric patient with late-onset pompe disease
por: Cao, Amanda, et al.
Publicado: (2023)

Electroconvulsive therapy is associated with increased immunoreactivity of neuroplasticity markers in the hippocampus of depressed patients
por: Loef, Dore, et al.
Publicado: (2023)

Two Factors in Face Recognition: Whether You Know the Person’s Face and Whether You Share the Person’s Race
por: Zhou, Xingchen, et al.
Publicado: (2021)

A novel seven-octapeptide repeat insertion in the prion protein gene (PRNP) in a Dutch pedigree with Gerstmann–Sträussler–Scheinker disease phenotype: comparison with similar cases from the literature
por: Jansen, Casper, et al.
Publicado: (2010)

Early and late-onset Alzheimer's disease: What are the differences?
por: Awada, Adnan A.
Publicado: (2015)

Movement disorders are linked to TDP-43 burden in the substantia nigra of FTLD-TDP brain donors
por: Fiondella, Luigi, et al.
Publicado: (2023)

Radiomic Features of the Hippocampus for Diagnosing Early-Onset and Late-Onset Alzheimer’s Disease
por: Du, Yang, et al.
Publicado: (2022)

Early‐onset Alzheimer's disease explained by polygenic risk of late‐onset disease?
por: Mantyh, William G., et al.
Publicado: (2023)

The What, the When, and the Whether of Intentional Action in the Brain: A Meta-Analytical Review
por: Zapparoli, Laura, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_66rtq0di1u3tcrb6bbq633rchr